| Literature DB >> 35164334 |
Agnieszka Kania1, Waldemar Tejchman1, Anna M Pawlak2, Krystian Mokrzyński2, Bartosz Różanowski1, Bogdan M Musielak3, Magdalena Greczek-Stachura1.
Abstract
Thiohydantoin and quinolone derivatives have attracted researchers' attention because of a broad spectrum of their medical applications. The aim of our research was to synthesize and analyze the antimicrobial properties of novel 2-thiohydantoin and 2-quinolone derivatives. For this purpose, two series of hybrid compounds were synthesized. Both series consisted of 2-thiohydantoin core and 2-quinolone derivative ring, however one of them was enriched with an acetic acid group at N3 atom in 2-thiohydantoin core. Antibacterial properties of these compounds were examined against bacteria: Staphylococcus aureus, Bacillus subtilis, Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae. The antimicrobial assay was carried out using a serial dilution method to obtain the MIC. The influence of blue light irradiation on the tested compounds was investigated. The relative yield of singlet oxygen (1O2*, 1Δg) generation upon excitation with 420 nm was determined by a comparative method, employing perinaphthenone (PN) as a standard. Antimicrobial properties were also investigated after blue light irradiation of the suspensions of the hybrids and bacteria placed in microtitrate plates. Preliminary results confirmed that some of the hybrid compounds showed bacteriostatic activity to the reference Gram-positive bacterial strains and a few of them were bacteriostatic towards Gram-negative bacteria, as well. Blue light activation enhanced bacteriostatic effect of the tested compounds.Entities:
Keywords: antibacterial test activity; blue light activation; hybrid of 2-thiohydantoin and 2-quinolone derivative; singlet oxygen generation
Mesh:
Substances:
Year: 2022 PMID: 35164334 PMCID: PMC8839260 DOI: 10.3390/molecules27031069
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Synthesis of 1-acetyl-2-thiohydantoin and its condensation with 2-chloroquinoline-3-carbaldehyde derivatives.
Scheme 2Synthesis of 2-thiohydantoin-3-acetic acid its condensation with 2-chloro-3-quinolinecarboxaldehyde derivatives.
Figure 1(A) Time-resolved singlet oxygen (1O2, 1Δg) phosphorescence at 1270 nm detected in DMSO: ethanol solutions (1:1, v/v) of perinaphtenone (PN) and selected samples (4a and 5a) upon excitation with 420 nm laser pulses at 35% and 100% of laser energy, respectively. (B) Dependence of the initial intensity of 1O2 (1Δg) phosphorescence generated by PN and selected samples on relative excitation energy.
Figure 2Singlet oxygen (1O2, 1Δg) phosphorescence decay detected at 1270 nm after laser excitation of selected samples: 4b (A) and 4d (B) in DMSO: ethanol solution (1:1, v/v) with 420 nm. Studied samples solutions were equilibrated with air (black) or saturated with argon (grey).
Relative efficiency of singlet oxygen generation by studied samples calculated against the standard.
| Sample | Relative Efficiency |
|---|---|
| PN (standard) | 100 |
|
| 12.43 (±0.02) |
|
| 10.90 (±1.07) |
|
| 10.23 (±0.93) |
|
| 9.81 (±0.24) |
|
| 8.54 (±0.23) |
|
| 7.98 (±0.56) |
|
| 7.71 (±0.98) |
|
| 5.91 (±0.66) |
|
| 5.77 (±1.14) |
|
| 5.66 (±0.15) |
|
| 4.93 (±0.22) |
|
| 3.93 (±2.10) |
MIC (μg/mL), MBC (μg/mL) of 4a, 4b, 4c, 4d, and 4e towards reference Gram-positive and Gram-negative bacterial strains in dark conditions.
| Microorganism | 4a | 4b | 4c | 4d | 4e | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | |
|
| nd | nd | nd | nd | nd | nd | nd | nd | 500 | nd |
|
| nd | nd | nd | nd | nd | nd | nd | nd | 1000 | nd |
|
| nd | nd | nd | nd | nd | nd | 250 | nd | 31.25 | 1000 |
|
| nd | nd | 7.82 | 250 | nd | nd | 7.82 | 250 | 7.82 | 500 |
|
| nd | nd | 7.82 | 125 | nd | nd | 125 | nd | 31.25 | 1000 |
|
| nd | nd | nd | nd | nd | nd | 7.82 | 250 | 62.5 | nd |
nd—not determined.
MIC (μg/mL), MBC (μg/mL) of 4f, 5b, 5c, 5e, and 5f towards reference Gram-positive and Gram-negative bacterial strains in dark conditions.
| Microorganism | 4f | 5b | 5c | 5e | 5f | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | |
|
| 62.5 | 1000 | nd | nd | nd | nd | nd | nd | 500 | nd |
|
| 31.25 | 500 | nd | nd | nd | nd | nd | nd | 250 | nd |
|
| 62.5 | 1000 | nd | nd | nd | nd | nd | nd | 250 | nd |
|
| 62.5 | 1000 | 250 | nd | 62.5 | 1000 | nd | nd | 250 | nd |
|
| 31.25 | 500 | 250 | nd | 62.5 | 1000 | nd | nd | 250 | nd |
|
| 31.25 | 500 | 250 | nd | 125 | nd | nd | nd | 62.5 | 1000 |
nd—not determined.
MBC to MIC ratios calculated for the compounds showing an antibacterial activity in the dark conditions.
| Microorganism | 4b | 4d | 4e | 4f | 5b | 5c | 5f |
|---|---|---|---|---|---|---|---|
|
| - | - | - | 16 | - | - | - |
|
| - | - | - | 16 | - | - | - |
|
| - | - | 32 | 16 | - | - | - |
|
| 32 | 32 | 64 | 16 | - | 16 | - |
|
| 16 | - | 32 | 16 | - | 16 | - |
|
| - | 32 | - | 16 | - | - | 16 |
MIC (μg/mL), MBC (μg/mL), and MBC/MIC ratio of ciprofloxacin towards reference Gram-positive and Gram-negative bacterial strains.
| Microorganism | Ciprofloxacin | ||
|---|---|---|---|
| MIC (μg/mL) | MBC (μg/mL) | MBC/MIC Ratio | |
| 0.24 | 0.48 | 2 | |
| 0.26 | 0.31 | 1.19 | |
| 7.81 | 7.81 | 1 | |
| 1 | 1 | 1 | |
| 7.81 | 7.81 | 1 | |
| 0.98 | 0.98 | 1 | |
MIC (μg/mL), MBC (μg/mL) of 4a, 4b, 4c, 4d, and 4e towards reference Gram-positive and Gram-negative bacterial strains upon blue light irradiation (see text for details).
| Microorganism | 4a | 4b | 4c | 4d | 4e | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | |
|
| nd | nd | 125 | 1000 | nd | nd | 7.82 | 250 | 500 | nd |
|
| nd | nd | 7.82 | 250 | 3.91 | 125 | 3.91 | 125 | 3.91 | 3.91 |
|
| nd | nd | 62.5 | 1000 | nd | nd | 62.5 | 1000 | 15.63 | 500 |
|
| nd | nd | 7.82 | 250 | nd | nd | 7.82 | 250 | 15.63 | 500 |
|
| nd | nd | 7.82 | 125 | nd | nd | 3.91 | 125 | 31.25 | 1000 |
|
| nd | nd | 7.82 | 125 | nd | nd | 3.91 | 125 | 3.91 | 250 |
nd—not determined.
MIC (μg/mL), MBC (μg/mL) of 4f, 5b, 5c, 5e, and 5f towards reference Gram-positive and Gram-negative bacterial strains upon blue light irradiation (see text for details).
| Microorganism | 4f | 5b | 5c | 5e | 5f | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | MIC (μg/mL) | MBC (μg/mL) | |
|
| 62.5 | 1000 | nd | nd | nd | nd | nd | nd | 500 | nd |
|
| 7.82 | 125 | nd | nd | 3.91 | 3.91 | nd | nd | 7.82 | 250 |
|
| 62.5 | 1000 | nd | nd | 62.5 | 1000 | nd | nd | 250 | nd |
|
| 62.5 | 1000 | 31.25 | 1000 | 62.5 | 1000 | nd | nd | 62.5 | nd |
|
| 3.91 | 250 | 125 | 1000 | 62.5 | 1000 | nd | nd | 15.63 | 500 |
|
| 3.91 | 250 | 125 | 1000 | 3.91 | 250 | nd | nd | 3.91 | 250 |
nd—not determined.
The MBC to MIC ratios calculated for the compounds showing an antibacterial activity upon blue light irradiation.
| Microorganism | 4b | 4d | 4e | 4f | 5b | 5c | 5f |
|---|---|---|---|---|---|---|---|
|
| 8 | 32 | - | 16 | - | - | - |
|
| 32 | 32 | 1 | 16 | - | 1 | - |
|
| 16 | 16 | 32 | 16 | - | 16 | - |
|
| 32 | 32 | 32 | 16 | 32 | 16 | - |
|
| 16 | 32 | 32 | 64 | 8 | 16 | 32 |
|
| 16 | 32 | 64 | 64 | 8 | 64 | 64 |
Figure 3Atom-numbering scheme of the tested compounds.